| 2024-09-30 |
Registry of genetic alterations of Taiwan non-small cell lung cancer by comprehensive next-generation sequencing: A real-world cohort study-Taiwan cooperative oncology group T1521 |
JCO Global Oncology. 2024 Sep 30;10:Article number e2400125. |
 |
| 2024-06 |
Systemic treatments in pancreatic cancer: Taiwan pancreas society recommendation |
Biomedical Journal. 2024 Jun;47(3):Article number 100696. |
|
| 2023-09-01 |
The experience of neoadjuvant chemotherapy versus upfront surgery in resectable pancreatic cancer. a cross sectional study |
International Journal of Surgery. 2023 Sep 1;109(9):2614-2623. |
|
| 2023-06 |
Phase 1 studies of D07001-F4 and D07001-softgel capsule: Oral metronomic gemcitabine in subjects with advanced solid tumors |
Journal of Clinical Oncology. 2023 Jun;41(16, Suppl.):Meeting Abstract 3148. |
|
| 2023-04 |
Elevated PD-L1 expression and microsatellite instability in elderly patients with gastric cancer |
Journal of Immunotherapy. 2023 Apr;46(3):111-119. |
|
| 2023-02-05 |
Real-world data validation of NAPOLI-1 nomogram for the prediction of overall survival in metastatic pancreatic cancer |
Cancers. 2023 Feb 5;15(4):Article number 1008. |
|
| 2023-02 |
The association between UGT1A1 polymorphisms and treatment toxicities of liposomal irinotecan |
ESMO Open. 2023 Feb;8(1):Article number 100746. |
|
| 2023-01-21 |
Adjuvant therapy in biliary tract cancers: Oral fluoropyrimidine as a beginning |
Lancet. 2023 Jan 21-27;401(10372):170-171. |
|
| 2023-01 |
A G-quadruplex stabilizer, CX-5461 combined with two immune checkpoint inhibitors enhances in vivo therapeutic efficacy by increasing PD-L1 expression in colorectal cancer |
Neoplasia. 2023 Jan;35:Article number 100856. |
|
| 2022-12-15 |
An integrated microfluidic system for cholangiocarcinoma diagnosis from bile by using specific affinity probes |
Sensors and Actuators B-Chemical. 2022 Dec 15;373:Article number 132724. |
|
| 2022-11-01 |
Revisiting the cerebral hemodynamics of awake, freely moving rats with repeated ketamine self-administration using a miniature photoacoustic imaging system |
Neurophotonics. 2022 Nov 01;9(4):Article number 045003. |
|
| 2022-11 |
CHK2 activation contributes to the development of oxaliplatin resistance in colorectal cancer |
British Journal of Cancer. 2022 Nov;127(9):1615-1628. |
|
| 2022-10 |
The immune microenvironment features and response to immunotherapy in EBV-associated lymphoepithelioma-like cholangiocarcinoma |
Hepatology International. 2022 Oct;16(5):1137-1149. |
|
| 2022-10 |
Impaired chromatin remodeling predicts better survival to modified gemcitabine and S-1 plus nivolumab in advanced biliary tract Cancer: A phase II T1219 study |
Clinical Cancer Research. 2022 Oct 3;28(19):4248-4257. |
|
| 2022-10 |
An integrated microfluidic device for automated detection of cancer cells from bile for cholangiocarcinoma prognosis |
MicroTAS 2022 - 26th International Conference on Miniaturized Systems for Chemistry and Life Sciences. 2022 Oct:229-230. |
|
| 2022-09-15 |
Predictive value of albumin combined with neutrophil-to-lymphocyte ratio for efficacy and safety profiles in patients with pancreatic ductal adenocarcinoma receiving liposomal irinotecan plus 5-fluorouracil and leucovorin |
American Journal of Cancer Research. 2022 Sep 15;12(9):4267-4278. |
|
| 2022-09 |
A prospective phase II study of biweekly S-1, leucovorin, and gemcitabine in elderly patients with locally advanced or metastatic pancreatic adenocarcinoma – The Taiwan Cooperative Oncology Group T1217 study |
European Journal of Cancer. 2022 Sep;173:123-132. |
|
| 2022-07 |
Improved survival with neoadjuvant chemotherapy in stage III pancreatic cancer: A single institutional experience |
Annals of Oncology. 2022 Jul;33(Suppl. 6):S535. |
|
| 2022-07 |
A phase II trial of nivolumab, gemcitabine and S-1 as the frst-line treatment in patients with biliary tract cancer |
Annals of Oncology. 2022 Jul;33(Suppl. 6):S478. |
|
| 2022-06-26 |
The differential clinical impacts of cachexia and sarcopenia on the prognosis of advanced pancreatic cancer |
Cancers. 2022 Jun 26;14(13):Article number 3137. |
|
| 2022-06-22 |
Dosing pattern and early cumulative dose of liposomal irinotecan in metastatic pancreatic cancer: A real-world multicenter study |
Frontiers in Oncology. 2022 Jun 22;12:Article number 800842. |
|
| 2022-06-16 |
Cancer-cell-derived cell-free DNA can predict distant metastasis earlier in pancreatic cancer: A prospective cohort study |
Therapeutic Advances in Medical Oncology. 2022 Jun 16;14:1-13. |
|
| 2022-06-02 |
Transferrin and prealbumin identify esophageal cancer patients with malnutrition and poor prognosis in patients with normal albuminemia: A cohort study |
Nutrition and Cancer. 2022 Jun 2;74(10):3546-3555. |
|
| 2022-06 |
Effect of previous conventional irinotecan treatment in patients with pancreatic cancer being treated with liposomal irinotecan plus 5-fluorouracil and leucovorin |
Journal of Hepato-Biliary-Pancreatic Sciences. 2022 Jun;54(5):607-612. |
|
| 2022-06 |
Comparative genomic analysis and its prognostic impact on survival between viral hepatitis-related and non-viral hepatitis intrahepatic cholangiocarcinoma |
Journal of Clinical Oncology. 2022 Jun;40(16, Suppl.):Abstract number 4120. |
|
| 2022-05-15 |
Improved survival with induction chemotherapy and conversion surgery in locally advanced unresectable pancreatic cancer: A single institution experience |
American Journal of Cancer Research. 2022 May 15;12(5):2189-2202. |
|
| 2022-04-15 |
The impact of spleen volume on the survival of metastatic pancreatic adenocarcinoma patients receiving nanoliposomal irinotecan |
American Journal of Cancer Research. 2022 Apr 15;12(4):1884-1898. |
|
| 2022-04 |
A phase II randomised trial of induction chemotherapy followed by concurrent chemoradiotherapy in locally advanced pancreatic cancer: the Taiwan Cooperative Oncology Group T2212 study |
British Journal of Cancer. 2022 Apr;126(7):1018-1026. |
|
| 2022-02-01 |
A prospective phase II study of biweekly S-1, leucovorin and gemcitabine in elderly patients with locally advanced or metastatic pancreatic adenocarcinoma |
Journal of Clinical Oncology. 2022 Feb 01;40(4, Suppl.):550. |
|
| 2022-02 |
Phase 1 study of nanoliposomal irinotecan in combination with trifluridine/tipiracil in refractory solid tumors |
Journal of Clinical Oncology. 2022 Feb;40(4, Suppl.):660. |
|
| 2021-11-20 |
Liposomal irinotecan pre-emptive dose reduction in patients with pancreatic ductal adenocarcinoma: 667 patients’ experience within a population-based study |
Therapeutic Advances in Medical Oncology. 2021 Nov 20;Article in Press. |
|
| 2021-11-01 |
Exfoliated tumor cells in bile as a promising indicator of disease status in cholangiocarcinoma |
Sensors and Actuators B: Chemical. 2021 Nov 01;346:Article number 130526. |
|
| 2021-09 |
A phase II trial of nivolumab and gemcitabine and S-1 as the first-line treatment in patients with advanced biliary tract cancer |
Annals of Oncology. 2021 Sep;32(Suppl. 5):S377. |
|
| 2021-07-23 |
AUY922 induces retinal toxicity through attenuating TRPM1 |
Journal of Biomedical Science. 2021 Jul 23;28:Article number 55. |
|
| 2021-07-15 |
No association between alcohol consumption and pancreatic cancer even among individuals genetically susceptible to the carcinogenicity of alcohol |
Scientific Reports. 2021 Jul 15;11:Article number 14567. |
|
| 2021-06-12 |
Phase 1b study of pegylated arginine deiminase (ADI-PEG 20) plus Pembrolizumab in advanced solid cancers |
Oncoimmunology. 2021 Jun 12;10(1):Article number 1943253. |
|
| 2021-06-07 |
In vivo assessment of hypoxia levels in pancreatic tumors using a dual-modality ultrasound/photoacoustic imaging system |
Micromachines. 2021 Jun 7;12(6):Article number 668. |
|
| 2021-05-14 |
Esophageal fistula after definitive concurrent chemotherapy and intensity modulated radiotherapy for esophageal squamous cell carcinoma |
PLoS ONE. 2021 May 14;16(5):Article number e0251811. |
|
| 2021-05 |
TCOG T5217 trial: A phase II randomized study of SLOG versus modified FOLFIRINOX as the first-line treatment in locally advanced or metastatic pancreatic ductal adenocarcinoma |
Journal of Clinical Oncology. 2021 May;39(15, Suppl.):4143. |
|
| 2021-05 |
A phase 2 study of liposomal irinotecan with 5-fluorouracil and leucovorin in squamous cell carcinoma of head and neck or esophagus after prior platinum-based chemotherapy or chemoradiotherapy |
Journal of Clinical Oncology. 2021 May;39(15, Suppl.):Abstract number 6025. |
|
| 2021-04 |
Phase I dose-escalation study of SCB01A, a microtubule inhibitor with vascular disrupting activity, in patients with advanced solid tumors |
Oncologist. 2021 Apr;26(4):e567-e579. |
|
| 2021-03-01 |
Phase I dose escalation study of sorafenib plus S-1 for advanced solid tumors |
Scientific Reports. 2021 Mar 1;11:Article number 4834. |
|
| 2021-01-13 |
Development of possible next line of systemic therapies for gemcitabine-resistant biliary tract cancers: A perspective from clinical trials |
Biomolecules. 2021 Jan 13;11(1):Article number 97. |
|
| 2020-12-29 |
Modified gemcitabine, S-1, and leucovorin combination for patients with newly diagnosed locally advanced or metastatic pancreatic adenocarcinoma: A multi-center retrospective study in Taiwan |
PLoS ONE. 2020 Dec 29;15(12):Article number e0244487. |
|
| 2020-11-13 |
The impact of liposomal irinotecan on the treatment of advanced pancreatic adenocarcinoma: Real-world experience in a Taiwanese cohort [Erraturm: Scientific Reports. 2020 May 4;10:Article number 7420.] |
Scientific Reports. 2020 Nov 13;10:Article number 20199. |
|
| 2020-11-01 |
Aptamer probed isolation of circulating tumor cells in cholangiocarcinoma patients |
Sensors and Actuators B: Chemical. 2020 Nov 1;322:Article number 128569. |
|
| 2020-11 |
An integrated microfluidic platform for cholangiocarcinoma diagnosis from clinical bile juice samples by utilizing multiple affinity reagents |
2020 IEEE 15th International Conference on Nano/Micro Engineered and Molecular System (IEEE Nems 2020). 2020 Nov:261-264. |
|
| 2020-10 |
Multicentre, phase II study of gemcitabine and S-1 in patients with advanced biliary tract cancer: TG1308 study |
Liver International. 2020 Oct;40(10):2535-2543. |
|
| 2020-10 |
Psychosocial illness impacts of Taiwanese cancer survivors |
Quality of Life Research. 2020 Oct;29(Suppl. 1):S91. |
|
| 2020-09-22 |
Cardiac radiation dose predicts survival in esophageal squamous cell carcinoma treated by definitive concurrent chemotherapy and intensity modulated radiotherapy |
Radiation Oncology. 2020 Sep 22;15:Article number 221. |
|
